(Reuters) – Merck said on Thursday its treatment for a type of uterus cancer did not meet the main goal of disease-free survival in a late-stage trial.
(Reporting by Christy Santhosh in Bengaluru; Editing by Shounak Dasgupta)
Brought to you by www.srnnews.com
